Multilingual SEIR public opinion propagation model with social enhancement mechanism and cross transmission mechanisms.

Multilingual SEIR public opinion propagation model with social enhancement mechanism and cross transmission mechanisms.

Publication date: Dec 28, 2024

The propagation of public opinion in multilingual environments presents unique challenges due to the diversity of languages, cultures, and values. This study develops an SEIR-based model tailored for multilingual contexts, incorporating mechanisms such as social enhancement, forgetting, and cross-transmission. The model’s purpose is to improve transparency, inclusivity, and effectiveness in public opinion management, particularly in diverse linguistic settings. By emphasizing democratic engagement and avoiding social control, the model provides tools for managing public opinion that promote fairness and transparency. The model was validated using real Twitter data related to COVID-19 across multiple languages, including English, Spanish, and Catalan. Key results demonstrate that the model effectively captures the dynamics of opinion propagation, particularly in languages with fewer users, where opinion spread tends to be more predictable. By addressing cultural and linguistic differences, this study offers an inclusive approach to public opinion management. The inclusivity ensures that different cultural groups, regardless of language, are fairly represented in public discourse. This research contributes to the ethical management of public opinion, providing valuable insights for policymakers and analysts in multilingual societies.

Open Access PDF

Concepts Keywords
Democratic COVID-19
Forgetting Cross-transmission mechanism
Insights Humans
Spanish Language
Twitter Models, Theoretical
Multilingual public opinion
Multilingualism
Optimal management strategy
Public Opinion
SARS-CoV-2
SEIR model
Social enhancement effect
Social Media

Semantics

Type Source Name
disease MESH COVID-19
disease IDO process
disease MESH infectious diseases
drug DRUGBANK Coenzyme M
disease IDO production
drug DRUGBANK Methionine
drug DRUGBANK Sulpiride
disease MESH emergencies
disease MESH panic
disease IDO history
disease IDO quality
drug DRUGBANK Isoxaflutole
pathway REACTOME Reproduction
disease MESH secondary infections
disease MESH infections
disease IDO susceptibility
drug DRUGBANK Huperzine B
disease IDO infection
drug DRUGBANK Alpha-methyltryptamine

Original Article

(Visited 1 times, 1 visits today)